China's Calcium Acetate Market Softens Further as Competitive Supply Weighs on Prices

China's Calcium Acetate market remained under pressure throughout July 2026, extending the weakness that began with a 1.89% month-on-month decline in June. The market continued to soften as sluggish domestic and export demand outweighed stable production, while comfortable inventories and favourable manufacturing economics encouraged suppliers to maintain competitive export offers. Looking ahead, market participants anticipate the bearish trend will persist into August amid seasonal demand weakness and cautious procurement across major end-use industries.

During July, supply-demand fundamentals remained tilted in buyers' favour. Chinese Calcium Acetate producers continued operating at stable production rates with no significant maintenance shutdowns reported, ensuring sufficient product availability across domestic and export markets. Inventories remained comfortable as production consistently exceeded fresh order inflows. On the demand side, overseas Calcium Acetate buyers from Southeast Asia, South America, and the Middle East maintained a cautious procurement strategy amid adequate inventories and subdued downstream activity. Domestic Calcium Acetate consumption also remained moderate as pharmaceutical, food additive, and wastewater treatment sectors largely relied on contract volumes rather than placing additional spot orders. Consequently, Calcium Acetate suppliers continued offering competitive FOB quotations to stimulate export interest, but transaction activity remained limited throughout the month. The absence of any significant logistics disruptions or raw material shortages further reinforced the prevailing bearish market sentiment.

The weakness observed in July followed the bearish momentum established in June, when Calcium Acetate prices declined by 1.89% amid easing feedstock costs and softer export demand. Lower raw material prices reduced manufacturing costs, enabling producers to lower FOB offers while maintaining healthy operating margins. Stable production, rising inventories, and cautious purchasing from key importing countries laid the foundation for the continued weakness witnessed throughout July.

Looking ahead, the China Calcium Acetate market is expected to remain under downward pressure through August before any meaningful recovery emerges later in the third quarter. Seasonal demand weakness is likely to continue restricting procurement from industrial consumers, while export demand is expected to remain moderate due to sufficient inventories across major importing markets. Lower feedstock costs should continue supporting favourable production economics, encouraging manufacturers to maintain steady operating rates and competitive pricing strategies.

However, Calcium Acetate procurement activity could gradually improve toward September as overseas buyers begin replenishing inventories ahead of fourth-quarter production schedules. Unless unexpected supply disruptions, freight constraints, or stronger-than-expected export orders tighten market availability, Calcium Acetate prices are anticipated to decline further in August, with broader market recovery likely only during late Q3 as seasonal restocking gains momentum.